Swiss Tropical & Public Health Institute — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Swiss Tropical & Public Health Institute appears in 20 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials20

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

20 shown

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan AfricaNCT05881447 · lead sponsor · 2023-06-21

Tolerability of Lopinavir Versus Dolutegravir for Children and Adolescents Living With HIVNCT05426421 · lead sponsor · 2022-07-11

Viral Load Triggered ART Care in LesothoNCT04527874 · lead sponsor · 2020-10-14

Genotype-Informed Versus Empiric Management of VirEmiaNCT04233242 · lead sponsor · 2020-03-03

Dolutegravir in Real Life in LesothoNCT04238767 · lead sponsor · 2020-02-10

Short Adherence Intervention for Viral Re-suppressionNCT03242980 · lead sponsor · 2017-05-18

Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural LesothoNCT02692027 · lead sponsor · 2016-02-01

Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural LesothoNCT02126696 · lead sponsor · 2014-05-01

Etiologies of Fever Among Adults in Dar es SalaamNCT01947075 · lead sponsor · 2013-07-01

Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?NCT00817713 · lead sponsor · 2009-01-01

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of TuberculosisNCT05452616 · collaborator · 2022-10-19

TB-CAPT EXULTANT - HIVNCT04568967 · collaborator · 2022-09-05

Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South AfricaNCT03809364 · collaborator · 2021-11-01

Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in EswatiniNCT04183413 · collaborator · 2021-11-01

FujiLAM Prospective Evaluation TrialNCT04089423 · collaborator · 2019-12-13

Peer-Educator-coordinated vs Nurse-coordinated ART Refill for Adolescents and Young Adults Living With HIV in LesothoNCT03969030 · collaborator · 2019-11-01

Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian AdultsNCT03420053 · collaborator · 2018-02-07

"Switch Either Near Suppression Or THOusand"NCT03088241 · collaborator · 2017-08-01

Immunogenicity and Safety of Vaccinations in Immunocompromised PersonsNCT01947465 · collaborator · 2013-10-01

Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan AfricaNCT03458338 · collaborator · 2010-12-08

Drugs studied in this sponsor's trials

1 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Swiss Tropical & Public Health Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

dolutegravir RxCUI 1433868 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator10

lead sponsor10

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.